Search Results

There are 4945 results for: content related to: Bosentan for digital ulcers in patients with systemic sclerosis

  1. Successful treatment with bosentan for refractory digital ulcers in a patient with systemic lupus erythematosus

    The Journal of Dermatology

    Volume 35, Issue 7, July 2008, Pages: 447–451, Yayoi NAGAI, Akira SHIMIZU and Osamu ISHIKAWA

    Article first published online : 10 JUL 2008, DOI: 10.1111/j.1346-8138.2008.00500.x

  2. Effects of bosentan on nondigital ulcers in patients with systemic sclerosis

    British Journal of Dermatology

    Volume 166, Issue 2, February 2012, Pages: 417–421, T. Taniguchi, Y. Asano, M. Hatano, Z. Tamaki, M. Tomita, T. Kawashima, M. Miyazaki, H. Sumida, K. Akamata, T. Takahashi, Y. Ichimura, T. Toyama, M. Sugita, S. Noda, A. Yao, K. Kinugawa and S. Sato

    Article first published online : 5 DEC 2011, DOI: 10.1111/j.1365-2133.2011.10581.x

  3. Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1784–1805, Dr Jürgen Venitz, Dr Julia Zack, Dr Hunter Gillies, Dr Martine Allard, Ms Jean Regnault and Dr Christopher Dufton

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011423662

  4. You have full text access to this OnlineOpen article
    Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

    Arthritis & Rheumatism

    Volume 50, Issue 12, December 2004, Pages: 3985–3993, J. H. Korn, M. Mayes, M. Matucci Cerinic, M. Rainisio, J. Pope, E. Hachulla, E. Rich, P. Carpentier, J. Molitor, J. R. Seibold, V. Hsu, L. Guillevin, S. Chatterjee, H. H. Peter, J. Coppock, A. Herrick, P. A. Merkel, R. Simms, C. P. Denton, D. Furst, N. Nguyen, M. Gaitonde, Carol Black and RAPIDS-1 Study Group

    Article first published online : 8 DEC 2004, DOI: 10.1002/art.20676

  5. You have free access to this content
    Future treatments in systemic sclerosis

    The Journal of Dermatology

    Volume 37, Issue 1, January 2010, Pages: 54–70, Yoshihide ASANO

    Article first published online : 24 JAN 2010, DOI: 10.1111/j.1346-8138.2009.00758.x

  6. You have free access to this content
    Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 77, Issue 1, January 2014, Pages: 141–148, Christoph Markert, Yvonne Schweizer, Regina Hellwig, Theresia Wirsching, Klaus-Dieter Riedel, Juergen Burhenne, Johanna Weiss, Gerd Mikus and Walter E. Haefeli

    Article first published online : 20 DEC 2013, DOI: 10.1111/bcp.12177

  7. Pharmacokinetic Interaction Between Tadalafil and Bosentan in Healthy Male Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 5, May 2008, Pages: 610–618, Dr Rebecca E. Wrishko, Dr Jasper Dingemanse, Dr Albert Yu, Ms Christelle Darstein, Dr Diane L. Phillips and Mr Malcolm I. Mitchell

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008315315

  8. You have full text access to this OnlineOpen article
    Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis

    Arthritis & Rheumatism

    Volume 56, Issue 6, June 2007, Pages: 1985–1993, P. P. Sfikakis, C. Papamichael, K. S. Stamatelopoulos, D. Tousoulis, K. G. Fragiadaki, P. Katsichti, C. Stefanadis and M. Mavrikakis

    Article first published online : 25 MAY 2007, DOI: 10.1002/art.22634

  9. You have full text access to this OnlineOpen article
    Single- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole

    British Journal of Clinical Pharmacology

    Volume 53, Issue 6, June 2002, Pages: 589–595, Paul L. M. van Giersbergen, Atef Halabi and Jasper Dingemanse

    Article first published online : 24 JUN 2002, DOI: 10.1046/j.1365-2125.2002.01608.x

  10. Autopsy case of systemic sclerosis with severe pulmonary hypertension

    The Journal of Dermatology

    Volume 34, Issue 11, November 2007, Pages: 769–772, Yayoi NAGAI, Masayoshi YAMANAKA, Chie HASHIMOTO, Akihiko NAKANO, Akira HASEGAWA, Yuko TANAKA, Hideaki YOKOO, Yoichi NAKAZATO and Osamu ISHIKAWA

    Article first published online : 25 OCT 2007, DOI: 10.1111/j.1346-8138.2007.00381.x

  11. Influence of Mild Liver Impairment on the Pharmacokinetics and Metabolism of Bosentan, a Dual Endothelin Receptor Antagonist

    The Journal of Clinical Pharmacology

    Volume 43, Issue 1, January 2003, Pages: 15–22, Paul L. M. van Giersbergen, Gabriela Popescu, Frédéric Bodin and Jasper Dingemanse

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270002239701

  12. Key Articles and Guidelines in the Management of Pulmonary Arterial Hypertension: 2011 Update

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 6, June 2012, Pages: e134–e169, Samuel G. Johnson, Steven R. Kayser, Rebecca L. Attridge, Laura Duvall, Tyree H. Kiser, Rebecca Moote, Brent N. Reed, Jo E. Rodgers and Brian Erstad

    Article first published online : 30 MAR 2012, DOI: 10.1002/j.1875-9114.2012.01105.x

  13. You have full text access to this OnlineOpen article
    The effect of bosentan on the pharmacokinetics of digoxin in healthy male subjects

    British Journal of Clinical Pharmacology

    Volume 47, Issue 6, June 1999, Pages: 701–706, Cornelia Weber, Ludger Banken, Herbert Birnboeck, Stephane Nave and Rainer Schulz

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00946.x

  14. You have full text access to this OnlineOpen article
    Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study

    British Journal of Clinical Pharmacology

    Volume 68, Issue 6, December 2009, Pages: 948–955, Maurice Beghetti, Sheila G. Haworth, Damien Bonnet, Robyn J. Barst, Philippe Acar, Alain Fraisse, Dunbar D. Ivy, Xavier Jais, Ingram Schulze-Neick, Nazzareno Galiè, Adele Morganti, Jasper Dingemanse, Andjela Kusic-Pajic and Rolf M. F. Berger

    Article first published online : 1 SEP 2009, DOI: 10.1111/j.1365-2125.2009.03532.x

  15. Acute Hemodynamic Effects of Single-Dose Sildenafil When Added to Established Bosentan Therapy in Patients With Pulmonary Arterial Hypertension: Results of the COMPASS-1 Study

    The Journal of Clinical Pharmacology

    Volume 49, Issue 11, November 2009, Pages: 1343–1352, Dr Ekkehard Gruenig, Dr Evangelos Michelakis, Dr Jean-Luc Vachiéry, Dr Carmine Dario Vizza, Dr F. Joachim Meyer, Dr Martin Doelberg, Dr Doris Bach, Dr Jasper Dingemanse and Dr Nazzareno Galiè

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009341182

  16. Skin perfusion pressure is useful for evaluating digital ulcer caused by systemic sclerosis

    The Journal of Dermatology

    Volume 39, Issue 5, May 2012, Pages: 481–482, Hiroshi KATO, Shoichi WATANABE and Akimichi MORITA

    Article first published online : 26 SEP 2011, DOI: 10.1111/j.1346-8138.2011.01334.x

  17. Mechanisms responsible for the altered pharmacokinetics of Bosentan: analysis utilizing rats with bile duct ligation-induced liver dysfunction

    Biopharmaceutics & Drug Disposition

    Volume 30, Issue 6, September 2009, Pages: 326–333, Isao Horiuchi, Yun-i Mori, Masato Taguchi, Fukiko Ichida, Toshio Miyawaki and Yukiya Hashimoto

    Article first published online : 28 JUL 2009, DOI: 10.1002/bdd.671

  18. You have full text access to this OnlineOpen article
    Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock

    British Journal of Pharmacology

    Volume 118, Issue 3, June 1996, Pages: 617–626, Eddie Weitzberg, Anette Hemsén, Anders Rudehill, Agnes Modin, Michael Wanecek and Jan M. Lundberg

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1996.tb15446.x

  19. You have full text access to this OnlineOpen article
    Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line

    British Journal of Pharmacology

    Volume 169, Issue 1, May 2013, Pages: 21–33, C Fahrmayr, J König, D Auge, M Mieth, K Münch, J Segrestaa, T Pfeifer, A Treiber and MF Fromm

    Article first published online : 12 APR 2013, DOI: 10.1111/bph.12126

  20. Bosentan treatment of digital ulcers related to autoimmune disorders

    Drug Development Research

    Volume 72, Issue 8, December 2011, Pages: 750–755, Carmen Cantisani, Carlo Mattozzi, Simona Giancristoforo, Sara D'Epiro and Antonio G. Richetta

    Article first published online : 13 DEC 2011, DOI: 10.1002/ddr.20483